Avoiding “MELD Purgatory”

Volume 6, Issue 8

In this issue, Drs. Jordan Feld and Lisette Krassenburg from the Toronto Centre for Liver Disease at the University of Toronto apply the information in their recent newsletter issue to clinical practice.

Take our post-test to claim CME credits.

To read a companion newsletter click here

Patients’ DMT Decision-Making

Volume 2, Issue 4

In this issue, Dr. Ellen Mowry, Associate Professor of Neurology and Epidemiology at the Johns Hopkins University School of Medicine, brings recent findings about patient decision-making and addressing common comorbidities into the MS clinic.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Clinical Perspectives on Barriers To HBV Care

Volume 6, Issue 6

In this podcast follow-up to their recent eViralHepatitis Review newsletter issue (Vol. 6, No. 5), Dr. Mandana Khalili and Dr. Michele Tana from the University of California, San Francisco discuss how their analysis of the newer published information can impact clinical practice.

Take our post-test to claim CME credits.

To read a companion newsletter click here

Clinical Perspective: New AEs from Newer ART

Volume 4, Issue 8

While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinical trial populations.

In this issue, Dr. Cody Chastain from the Division of Infectious Diseases at Vanderbilt University Medical Center discusses how these new findings can impact the clinical use of these new agents.

Take our post-test to claim CME credits.

To read a companion newsletter click here